This study is looking at why people with myelodysplastic syndromes (MDS), a type of blood cancer, might be more likely to develop heart problems. Researchers want to identify specific proteins in the blood, called inflammatory markers, that could help predict these heart issues. By understanding these markers better, the goal is to find new ways to detect and manage heart disease risks in people with MDS. You can join if you are at least 18 years old, have a confirmed MDS diagnosis, and are expected to live for at least 6 months. The study aims to enroll 30 participants. The main goal is to measure how these inflammatory markers change in your blood over 6 months.

Study design

This is an observational study, meaning you won't receive any new treatments. It plans to include 30 adult participants with Myelodysplastic Syndromes.

What's involved

You will have an initial visit, then weekly visits for 3 weeks, followed by monthly visits for 5 months. At each visit, you will provide a blood sample after not eating overnight.

Compensation

Not stated in the trial record.

Follow-up

Your blood markers will be measured over 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.